Sign in

Call for cheap generic drugs

UNAIDS urges nations including India, to go for compulsory licensing to ensure that the needy have access to cheap drugs to treat HIV/AIDS, reports Sanchita Sharma.

Updated on: Aug 21, 2007, 03:09:47 IST
Hindustan Times | By , Colombo
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

UNAIDS on Monday urged countries, including India, to opt for compulsory licensing under the Trips agreement to ensure people in need have access to cheap generic second-generation drugs to treat HIV/AIDS.

HT Image
HT Image



Compulsory licensing allows countries to manufacture or import cheaper generic (copycat) versions of patented life-saving drugs in a medical emergency.



India is the world's biggest manufacturer of cheap unpatented drugs in the world. "Governments cannot say they don't have money for the more expensive second-generation drugs and abandon people under free treatment under national programmes. Governments have the responsibility to ensure care and if needed, go for compulsory licensing to import or manufacture patented drugs. Other countries should follow the Thailand example," says JVR Prasada Rao, Director, Regional Support Team, UNAIDS.



India provides free first-generation drugs to 82,000 people living with HIV/AIDS. "India is one of the world's largest producers of second-generation anti-retrovirals used to treat HIV/AIDS and yet it does not provide it under its national programme," said Prasada Rao, who was a secretary in the Ministry of Health and Family Welfare.



India has the largest number of people living with HIV/AIDS in the Asia Pacific region. Of the 5.4 million people living with HIV/AIDS in the region, roughly half -- 2.47 million -- live in India. Yet India accounts for about a third of the people getting AIDS medicines under the government programme -- India accounts for 82,000 of the 235,000 people who get AIDS drugs under public health programmes in the region.



"Countries in the region would support Thailand that defied big pharma to save lives. I have been HIV-positive for 16 years, and if it wasn't for medicines, I would have died years ago," says Sheeba, regional coordinator, Asia Pacific Network of Positive People.

  • Sanchita Sharma
    ABOUT THE AUTHOR
    Sanchita Sharma

    Sanchita is the health & science editor of the Hindustan Times. She has been reporting and writing on public health policy, health and nutrition for close to two decades. She is an International Reporting Project fellow from Paul H. Nitze School of Advanced International Studies at the Bloomberg School of Public Health and was part of the expert group that drafted the Press Council of India’s media guidelines on health reporting, including reporting on people living with HIV.Read More

Get the latest headlines from US news and global updates from Pakistan, Nepal, UK, Bangladesh, Russia and US Iran war Live, get all the latest headlines in one place on Hindustan Times.